Background {#Sec1}
==========

*Bacillus anthracis*, the cause of anthrax in humans and animals, is an endospore-forming bacterium that can persist in the environment for many years. In the U.S., *B. anthracis* infections in animals occur in states that are enzootic for the disease, such as Texas, North and South Dakota, and Minnesota \[[@CR1]--[@CR5]\]. Anthrax outbreaks have occurred annually in livestock and wild game in Texas for the past decade. Outbreaks pertinent to this study include an outbreak in a cattle herd in July 2007 on a ranch north of San Angelo, Texas, and an outbreak in horses on an adjacent ranch in August 2007 \[[@CR6], [@CR7]\].

Identification of *B. anthracis* is commonly based on colony morphology (including hemolysis), capsule production, detection of virulence plasmids (pXO1 and pXO2) by real-time PCR, and susceptibility to lysis by gamma phage \[[@CR8]--[@CR10]\]. The gamma phage assay is widely used as a diagnostic test for *B. anthracis* in many laboratories due to ease and low cost of use. Recently, several studies have used gamma phage binding and lytic activity as the basis for newer diagnostic assays, such as using engineered phage for bioluminescent detection \[[@CR11]--[@CR16]\]. The specificity and sensitivity of gamma phage has been previously documented, and although the specificity for *B. anthracis* is very high (97%), a small number of isolates of close relatives, including examples of *Bacillus cereus* and *Bacillus thuringiensis*, are susceptible \[[@CR9], [@CR17]\]. In this study, we evaluated the specificity of the gamma phage assay in conjunction with other diagnostic tests to screen 700 spore-forming Texas soil isolates for identification of *B. anthracis*.

Methods {#Sec2}
=======

Texas soil collection and processing {#Sec3}
------------------------------------

Core soil samples were collected in September 2007 from two sites in Texas in or near the municipalities of Schertz and San Angelo. Schertz was chosen due to the previous identification of pathogenic *B. cereus* isolates (two clinical, one environmental) harboring *B. anthracis* toxin and/or capsule genes that were associated with fatal pneumonias in metal workers from the area in 2003 \[[@CR18]\]. San Angelo was chosen due to the recent anthrax outbreaks in cattle and horses mentioned above \[[@CR6], [@CR7]\]. Sterile 50 mL conical tubes were uncapped and twisted down into the soil to a depth of approximately 2.5--3.0 cm. The tubes containing the core samples were then re-capped and wrapped in parafilm. Samples were shipped at ambient temperature and subsequently stored at -- 30 °C until processing.

Three samples were selected for testing (one from Schertz and two from San Angelo), and 2--3 bacterial extractions were performed on each sample. For each extraction, approximately 3.5 g of soil were transferred to a sterile 15 mL conical tube. The soil was saturated with phosphate-buffered saline containing 0.3% Tween 20 (PBST) and an additional 1.0 mL of PBST was added, then the sample was vortexed at high speed for 1--3 min. To select for spore-forming bacteria, the samples were heat shocked at 65 °C for 30 min and allowed to settle. The supernatant was transferred to a 2.0 mL screw-cap tube, and briefly centrifuged at 2000--3000 rpm. The following amounts were plated to produce 20--50 colonies/plate: 100 µL of the undiluted supernatant was plated onto PLET (polymyxin, lysozyme, ethylenediaminetetraacetic acid, thallium acetate) agar plates, a selective medium for *B. anthracis* \[[@CR19]\], while 100 µL aliquots of a 1:20 dilution were plated onto 10 trypticase soy agar plates containing 5% sheep blood (SBA). Both PLET and SBA plates were incubated overnight at 37 °C. Seven hundred random single colonies were picked and streaked to SBA for isolation. Isolates were then streaked onto sporulation medium (agar containing tryptone, peptone, yeast extract, and manganous chloride) and incubated at 30 °C for 5--7 days. Spores were harvested in 25% glycerol in deionized water and stored as spore suspensions at -- 70 °C.

Isolate screening and identification {#Sec4}
------------------------------------

Phenotypic characteristics, including hemolysis and colony morphology on SBA (see Additional file [1](#MOESM1){ref-type="media"}), and gamma phage susceptibility were recorded for all isolates. Gamma phage testing was performed as previously described \[[@CR9]\], with susceptibility defined as any amount of lysis or reduced growth where gamma phage was applied. Cell lysates containing DNA were prepared as previously described \[[@CR8]\], and were tested using the Laboratory Response Network's real-time PCR assay for detection of the *B. anthracis* chromosome, and of virulence plasmids pXO1 and pXO2 genes (*pagA* and *capB*, respectively) \[[@CR8], [@CR17]\]. For isolates exhibiting susceptibility to gamma phage lysis, the cell wall (CW) and capsule (CAP) direct fluorescent antibody (DFA) assays were also performed as previously described \[[@CR10]\]. Gamma phage-susceptible isolates that were ruled-out for *B. anthracis* using the tests above were identified by 16S rRNA gene sequencing as previously described \[[@CR20]\]. For isolates that produced readable sequences, the sequences were compared to published type strain sequences (when applicable) in NCBI's GenBank database using BLAST, using a sequence similarity of 99--100%. The 16s rRNA sequences of isolates 2008723338, 2008723339, 2008723400, 2008723423, 200872372 and 2008723476 were deposited in GenBank with Accession Numbers KT254134, KT254135, KT254136, KT254137, KT254138 and KT254139, respectively. Isolates identified as belonging to the *B. cereus* group were further typed by multi locus sequence typing (MLST), performed as previously described \[[@CR21]\].

Findings {#Sec5}
========

Twenty-nine of the 700 isolates were susceptible to gamma phage lysis, with 20 exhibiting hemolysis on SBA and with variable colony morphologies (see Additional files [1](#MOESM1){ref-type="media"} and [2](#MOESM2){ref-type="media"}). One isolate was identified as *B. anthracis* (PCR positive for all targets, nonhemolytic, gamma phage-susceptible, and positive by CW- and CAP-DFA assays). The other 28 isolates were negative for all three *B. anthracis* PCR markers, including virulence genes *pagA* and *capB*, and all were negative for the CW-DFA and CAP-DFA assays except for isolate 2008723634, which was weakly positive for the CW-DFA assay. Based on the combined results of these tests, 28 of the 29 gamma phage-susceptible isolates were ruled out as *B. anthracis*. We calculated the specificity of the gamma phage test as 96% by dividing the number of true negatives by the sum of the number of true negatives plus the number of false positives, multiplied by 100 (see Table [1](#Tab1){ref-type="table"}). Twenty-five of these 28 isolates produced readable 16S rRNA gene sequences, and were identified as follows: six *Lysinibacillus* spp., one *Bacillus* sp., one *Solibacillus silvestris*, and 17 isolates could only be identified as "*B. cereus* group members" due to the inability to distinguish members of the *B. cereus* group based on 16S gene sequencing. Representative isolates from each group are shown in Fig. [1](#Fig1){ref-type="fig"}. The 16S sequence data was not analyzed for three isolates due to failure to amplify.Table 1Results of gamma phage susceptibility testingFinal identification^a^Totals*B. anthracis*Other spp.Gamma phage lysis Positive1^b^28^c^29 Negative0^d^671^e^671 Totals1699700^a^Final identification based on *B. anthracis* real-time PCR, 16S rRNA gene sequencing, and CW- and CAP-DFA^b^Number of true positives^c^Number of false positives^d^Number of false negatives^e^Number of true negatives Fig. 1Neighbor-joining dendrogram of 16S rRNA gene sequences, showing the relationship of isolates and representative isolates from each grouping (shown in bold) to a panel of related bacteria. Bootstrap values (based on 1000 replications) are given as percentages at branch nodes. *Brevibacillus brevis* is used as an outgroup for this analysis

Multi locus sequence typing was performed on all of the 17 *B. cereus* group isolates, however, only eight isolates produced usable gene segments for all seven alleles. All eight isolates were different sequence types (ST), and therefore, not multiple isolations of a single clone. Seven of the eight isolates were new STs, and were compared with other previously identified gamma phage-susceptible *B. cereus* isolates, as well as other *B. cereus*-group STs (Fig. [2](#Fig2){ref-type="fig"}) \[[@CR17], [@CR21]\]. None of the eight *B. cereus* group isolates identified cluster with previously identified gamma phage-susceptible isolates (ST-129, ST-130, or ST-132), however six of the isolates from this study did cluster closely together (Fig. [2](#Fig2){ref-type="fig"}) \[[@CR21]\]. The other two *B. cereus* group isolates (2008723644 and 2008723286) were identified as ST-502 or clustered nearest to ST-502, respectively.Fig. 2Relationships between *B. cereus* group member isolates of this study and select reference isolates using concatenated sequences from seven housekeeping alleles. Sequence types (STs) with previously identified gamma phage susceptible isolates are shown in bold, and isolates from this study with new STs are marked (asterisk). The tree was constructed using the neighbor joining method and percent bootstrap confidence levels were calculated using 1000 resamplings of the original data

In conclusion, the diagnostic tests used in this study showed high specificity (real-time PCR 100% and gamma phage 96%). Interestingly, despite reports of *B. cereus* isolates harboring pXO1 and pXO2 plasmids or some of their genes (*pag*A and *cap*B), these markers were not detected in any of the 700 isolates, except for the single *B. anthracis* isolate \[[@CR18], [@CR22]--[@CR24]\]. Though gamma phage susceptibility is considered specific for *B. anthracis*, rare false positives can occur due to the susceptibility of a few other species. To our knowledge, this is the first report of susceptible isolates outside the *Bacillus* genus. Though the isolates described in this study are of environmental origin rather than clinical, and are often thought of as contaminants in the clinical laboratory, most can be opportunistic pathogens \[[@CR25]\]. Therefore, it is important to note their existence, especially when new diagnostic methods are being developed using gamma phage or gamma phage proteins for the detection of *B. anthracis* in clinical or environmental samples \[[@CR11]--[@CR16]\].
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**Additional file 1: Table S1.** Colony morphologies of gamma phage-susceptible isolates on SBA after overnight incubation at 37 °C. **Additional file 2: Table S2.** Isolation, hemolysis, and identification results of gamma phage-susceptible isolates.

PCR

:   polymerase chain reaction

PBST

:   phosphate-buffered saline containing 0.3% Tween 20

PLET

:   polymyxin, lysozyme, ethylenediaminetetraacetic acid, thallium acetate

SBA

:   trypticase soy agar plates containing 5% sheep blood

CW-DFA

:   cell wall direct fluorescent antibody

CAP-DFA

:   capsule direct fluorescent antibody

MLST

:   multi locus sequence typing

ST

:   sequence type
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